These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21866144)

  • 1. Risk factors: Nanomaterials should be defined.
    Stamm H
    Nature; 2011 Aug; 476(7361):399. PubMed ID: 21866144
    [No Abstract]   [Full Text] [Related]  

  • 2. Don't define nanomaterials.
    Maynard AD
    Nature; 2011 Jul; 475(7354):31. PubMed ID: 21734686
    [No Abstract]   [Full Text] [Related]  

  • 3. Tighter nanotech regulations touted.
    Sanderson K
    Nature; 2009 Feb; 457(7230):647. PubMed ID: 19194417
    [No Abstract]   [Full Text] [Related]  

  • 4. Technology: Nanomaterials need flexible regulation.
    Wickson F
    Nature; 2011 Aug; 476(7360):283. PubMed ID: 21850092
    [No Abstract]   [Full Text] [Related]  

  • 5. The US must help set international standards for nanotechnology.
    Murashov V; Howard J
    Nat Nanotechnol; 2008 Nov; 3(11):635-6. PubMed ID: 18989319
    [No Abstract]   [Full Text] [Related]  

  • 6. Nanotechnology. EPA ponders voluntary nanotechnology regulations.
    Service RF
    Science; 2005 Jul; 309(5731):36. PubMed ID: 15994499
    [No Abstract]   [Full Text] [Related]  

  • 7. International standards for risk management in nanotechnology.
    Hatto P
    Nat Nanotechnol; 2009 Apr; 4(4):205; author reply 205-6. PubMed ID: 19350019
    [No Abstract]   [Full Text] [Related]  

  • 8. Nanotechnology in healthcare: are existing laws adequate?
    Munir AB; Yasin SH
    Eur J Health Law; 2007 Nov; 14(3):261-72. PubMed ID: 18229763
    [No Abstract]   [Full Text] [Related]  

  • 9. Insights into possibilities for grouping and read-across for nanomaterials in EU chemicals legislation.
    Mech A; Rasmussen K; Jantunen P; Aicher L; Alessandrelli M; Bernauer U; Bleeker EAJ; Bouillard J; Di Prospero Fanghella P; Draisci R; Dusinska M; Encheva G; Flament G; Haase A; Handzhiyski Y; Herzberg F; Huwyler J; Jacobsen NR; Jeliazkov V; Jeliazkova N; Nymark P; Grafström R; Oomen AG; Polci ML; Riebeling C; Sandström J; Shivachev B; Stateva S; Tanasescu S; Tsekovska R; Wallin H; Wilks MF; Zellmer S; Apostolova MD
    Nanotoxicology; 2019 Feb; 13(1):119-141. PubMed ID: 30182766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NANOtechnology: untold promise, unknown risk.
    Consum Rep; 2007 Jul; 72(7):40-5. PubMed ID: 17632953
    [No Abstract]   [Full Text] [Related]  

  • 11. Too small to overlook.
    Maynard A; Rejeski D
    Nature; 2009 Jul; 460(7252):174. PubMed ID: 19587746
    [No Abstract]   [Full Text] [Related]  

  • 12. Research strategies for safety evaluation of nanomaterials, part II: toxicological and safety evaluation of nanomaterials, current challenges and data needs.
    Holsapple MP; Farland WH; Landry TD; Monteiro-Riviere NA; Carter JM; Walker NJ; Thomas KV
    Toxicol Sci; 2005 Nov; 88(1):12-7. PubMed ID: 16120754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative analysis of modern approaches to risk estimation from artificially created nanoparticles and nanomaterials].
    Kazak AA; Stepanov EG; Gmoshinskiĭ IV; Khotimchenko SA
    Vopr Pitan; 2012; 81(4):11-7. PubMed ID: 23156045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The continuing uncertainty of nano risks and regulations.
    Chatterjee R
    Environ Sci Technol; 2008 Nov; 42(21):7733. PubMed ID: 19031851
    [No Abstract]   [Full Text] [Related]  

  • 15. Governance of nanotechnology and nanomaterials: principles, regulation, and renegotiating the social contract.
    Kimbrell GA
    J Law Med Ethics; 2009; 37(4):706-23. PubMed ID: 20122111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk assessment of engineered nanomaterials and nanotechnologies--a review.
    Savolainen K; Alenius H; Norppa H; Pylkkänen L; Tuomi T; Kasper G
    Toxicology; 2010 Mar; 269(2-3):92-104. PubMed ID: 20105448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The carcinogenic potential of nanomaterials, their release from products and options for regulating them.
    Becker H; Herzberg F; Schulte A; Kolossa-Gehring M
    Int J Hyg Environ Health; 2011 Jun; 214(3):231-8. PubMed ID: 21168363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safe handling of nanotechnology.
    Maynard AD; Aitken RJ; Butz T; Colvin V; Donaldson K; Oberdörster G; Philbert MA; Ryan J; Seaton A; Stone V; Tinkle SS; Tran L; Walker NJ; Warheit DB
    Nature; 2006 Nov; 444(7117):267-9. PubMed ID: 17108940
    [No Abstract]   [Full Text] [Related]  

  • 19. Nanomaterials: Confusing statements by Becker et al. (2010).
    Morfeld P
    Int J Hyg Environ Health; 2011 Sep; 214(5):411; author's reply 412. PubMed ID: 21621457
    [No Abstract]   [Full Text] [Related]  

  • 20. Nano rules fall foul of data gap.
    Samuel Reich E
    Nature; 2011 Dec; 480(7376):160-1. PubMed ID: 22158217
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.